EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Two myeloid leukemia cases with rare FLT3 fusions

Haijiao Zhang, Aleksandra Paliga, Evie Hobbs, Stephen Moore, Susan Olson, Nicola Long, Kim-Hien T Dao, Jeffrey W Tyner

Molecular Case Studies · 2018-12 · 4 (6) · a003079

DOI: 10.1101/mcs.a003079 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Case Studies, online erschienen am 17.12.2018. Verfasst von Haijiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon 97239, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic rearrangements involving FLT3 are rare and only recently have been detected in myeloid/lymphoid neoplasms associated with eosinophilia (MLN-eos) and chronic myeloproliferative disorders. Here we report two cases with FLT3 fusions in patients demonstrating mixed features of myelodysplastic/myeloproliferative neoplasms. In the first case, FLT3 was fused with a new fusion partner MYO18A in a patient with marrow features most consistent with atypical chronic myeloid leukemia; the second case involving ETV6 - FLT3 fusion was observed in a case with bone marrow features most consistent with chronic myelomonocytic leukemia. Notably, we observed that samples from both patients demonstrated FLT3 inhibitor (quizartinib and sorafenib) sensitivity in ex vivo drug screening assay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzothiazolesBone MarrowEosinophiliaHumansLeukemia, MyeloidLeukemia, Myelomonocytic, ChronicLymphomaMaleMiddle AgedMyelodysplastic-Myeloproliferative DiseasesMyosinsPhenylurea CompoundsProto-Oncogene Proteins c-etsRecombination, GeneticRepressor ProteinsSorafenibfms-Like Tyrosine Kinase 3ETS Translocation Variant 6 Protein

Stichwörter der Autor:innen

chronic myelomonocytic leukemiatransient myeloproliferative syndrome

Substanzen

BenzothiazolesMyosinsPhenylurea CompoundsProto-Oncogene Proteins c-etsRepressor ProteinsSorafenibfms-Like Tyrosine Kinase 3ETS Translocation Variant 6 ProteinquizartinibFLT3 protein, human

Autor:innen und Institutionen

  • Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon 97239, USA.
  • Division of Hematology and Medical Oncology, Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon 97239, USA.
  • Department of Molecular and Medical Genetics, Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon 97239, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Zhang, H., Paliga, A., Hobbs, E., Moore, S., Olson, S., Long, N., Dao, K. T., & Tyner, J. W. (2018). Two myeloid leukemia cases with rare FLT3 fusions. Molecular Case Studies, 4(6), a003079. https://doi.org/10.1101/mcs.a003079

Vancouver

Zhang H, Paliga A, Hobbs E, Moore S, Olson S, Long N, et al. Two myeloid leukemia cases with rare FLT3 fusions. Molecular Case Studies. 2018;4(6):a003079. doi:10.1101/mcs.a003079

BibTeX
@article{Zhang2018,
  author = {Zhang, Haijiao and Paliga, Aleksandra and Hobbs, Evie and Moore, Stephen and Olson, Susan and Long, Nicola and Dao, Kim-Hien T and Tyner, Jeffrey W},
  title = {Two myeloid leukemia cases with rare FLT3 fusions},
  journal = {Molecular Case Studies},
  year = {2018},
  volume = {4},
  number = {6},
  pages = {a003079},
  doi = {10.1101/mcs.a003079}
}
Kostenlos starten →